HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 80146502074

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80146502074 and manufactured by ABBOTT IRELAND DIAGNOSTIC DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Feb 14, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTIC DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.